Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
Source:
Nasdaq GlobeNewswire
/
06 Dec 2023 06:00:00 America/Chicago
N/A
Share on,